304271
Technology in Survey Data Collection: Cost-Effective Advances from Limited-Resource Settings
Data collection costs will be compared between two 5-year longitudinal cluster randomized controlled trials in Uganda with HIV/AIDS-infected and affected adolescent populations: Suubi+Adherence (PI: Ssewamala; 1R01HD074949-01); and Bridges to the Future (PI: Ssewamala; 1R01HD070727-01). Data collection costs using paper-based methods of the 736 HIV-positive adolescents in the Suubi+Adherence study will be compared to costs using computer assisted self-interviewing methods with an equally-sized sub-sample of the 1,410 total sample of HIV/AIDS-affected adolescents in the Bridges to the Future study.
Both studies take place in southern Uganda – a region facing scarcity and infrastructural challenges, analogous to rest of sub-Saharan Africa. Ssewamala and colleagues will demonstrate the cost-effectiveness of digital data collection compared to paper-based methods employed in previous and ongoing studies with a comparable demographic in the same study region.
The use of technology in survey data collection methods has implications for researchers and clinicians working in sub-Saharan Africa and other limited-resource settings with HIV/AIDS-affected adolescent populations.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practicePublic health or related research
Social and behavioral sciences
Learning Objectives:
Differentiate the costs and benefits of digital compared to manual field survey data collection methods in a limited-resource setting.
Keyword(s): Data Collection and Surveillance, HIV/AIDS
Qualified on the content I am responsible for because: I am qualified to be an abstract Author on the content because I am responsible for coordinating the data on the study to which the abstract pertains.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.